Tian Wang
Investor Relations Contact bij Beijing Mabworks Biotech Co., Ltd.
Profiel
Tian Wang is currently working as the Joint Secretary at Beijing Mabworks Biotech Co., Ltd.
since 2020.
Prior to this, Mr. Wang worked as a Manager at Zero2ipo Management Consulting Group Co. Ltd.
from 2016 to 2019.
Mr. Wang completed their graduate degree at the University of London in 2014 and their undergraduate degree at Newcastle University in 2013.
Actieve functies van Tian Wang
| Bedrijven | Functie | Begin |
|---|---|---|
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Investor Relations Contact | 01-03-2019 |
Eerdere bekende functies van Tian Wang
| Bedrijven | Functie | Einde |
|---|---|---|
| Zero2ipo Management Consulting Group Co. Ltd. | Corporate Officer/Principal | 01-03-2019 |
Opleiding van Tian Wang
| Newcastle University | Undergraduate Degree |
| University of London | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
| Zero2ipo Management Consulting Group Co. Ltd. |
